Abstract
Urothelial cancer (UC) of the bladder is a relatively common disease seen in Americans, especially those who have significant tobacco exposure history. While the signs and symptoms of UC can be straight-forward (e.g., hematuria, irritative voiding symptoms), a complete work-up is required to appropriately stage each patient. The work-up of UC consists of: a high level of suspicion for patients with hematuria to prevent missed or delayed diagnoses; an exam under anesthesia; imaging studies; urinary markers and cytology; cystoscopy and transurethral resection of the bladder tumor (TURBT), as well as potential repeat TURBT to prevent understaging and residual disease.
Keywords: Urothelial cancer, bladder cancer, TURBT, diagnosis
Current Cancer Therapy Reviews
Title: The Optimal Diagnosis of Urothelial Carcinoma of the Bladder
Volume: 7 Issue: 4
Author(s): Alan M. Nieder, Jeetu Nebhnani and Fernando J. Bianco
Affiliation:
Keywords: Urothelial cancer, bladder cancer, TURBT, diagnosis
Abstract: Urothelial cancer (UC) of the bladder is a relatively common disease seen in Americans, especially those who have significant tobacco exposure history. While the signs and symptoms of UC can be straight-forward (e.g., hematuria, irritative voiding symptoms), a complete work-up is required to appropriately stage each patient. The work-up of UC consists of: a high level of suspicion for patients with hematuria to prevent missed or delayed diagnoses; an exam under anesthesia; imaging studies; urinary markers and cytology; cystoscopy and transurethral resection of the bladder tumor (TURBT), as well as potential repeat TURBT to prevent understaging and residual disease.
Export Options
About this article
Cite this article as:
M. Nieder Alan, Nebhnani Jeetu and J. Bianco Fernando, The Optimal Diagnosis of Urothelial Carcinoma of the Bladder, Current Cancer Therapy Reviews 2011; 7 (4) . https://dx.doi.org/10.2174/157339411797642641
DOI https://dx.doi.org/10.2174/157339411797642641 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Molecular Targeting of Drug Delivery Systems to Cancer
Current Drug Targets Neuro-Transmitters in the Central Nervous System & their Implication in Learning and Memory Processes
Current Medicinal Chemistry Lipid-Based Drug Delivery Systems for Cancer Treatment
Current Drug Targets Reviewing the Role of Resveratrol as a Natural Modulator of Microglial Activities
Current Pharmaceutical Design Aminolevulinic Acid Derivatives and Liposome Delivery as Strategies for Improving 5-Aminolevulinic Acid- Mediated Photodynamic Therapy
Current Medicinal Chemistry Unsafe Abortion: The Silent Endemic; An Avoidable Cause of Maternal Mortality. A Review
Current Women`s Health Reviews Current Understanding of the Potential of Proteomics and Metabolomics Approaches in Cancer Chemoresistance: A Focus on Multiple Myeloma
Current Topics in Medicinal Chemistry Radiosensitization of Prostate Cancer by Soy Isoflavones
Current Cancer Drug Targets Natural Flora and Anticancer Regime: Milestones and Roadmap
Anti-Cancer Agents in Medicinal Chemistry Vasoactive Intestinal Peptide Receptors: A Molecular Target in Breast and Lung Cancer
Current Pharmaceutical Design Expression Profiles and Bioinformatics Analysis of Full-length circRNA Isoforms in Gliomas
Current Bioinformatics Managing Comorbidity in COPD: A Difficult Task
Current Drug Targets Occurrence and Severity of Adverse Reactions of Immune Checkpoint Inhibitors (PD-1 and PD L1) Based on Mordovian Dispensary Data Analysis
Current Cancer Therapy Reviews Designing Peptide Mimetics for the Treatment of Multiple Sclerosis
Mini-Reviews in Medicinal Chemistry Advances in Nanomedicine Towards Clinical Application in Oncology and Immunology
Current Pharmaceutical Biotechnology Engineered Nanoparticles in Cancer Therapy
Recent Patents on Drug Delivery & Formulation In Vivo Cellular Imaging for Translational Medical Research
Current Medical Imaging Antisense Targets to Enhance Hormone and Cytotoxic Therapies in Advanced Prostate Cancer
Current Drug Targets Sirtuin Modulators: Mechanisms and Potential Clinical Implications
Current Medicinal Chemistry BRCA1-Associated Triple-Negative Breast Cancer and Potential Treatment for Ruthenium-Based Compounds
Current Cancer Drug Targets